Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Patient-derived xenograft (PDX) models are important tools in precision medicine and for the development of targeted therapies to treat cancer patients. This study aimed to evaluate our precision medicine strategy that integrates genomic profiling and preclinical drug-screening platforms, in order to personalize cancer treatments using PDX models.<...
Alternative Titles
Full title
Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dea136f999e0427e8d95e30b283290dd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dea136f999e0427e8d95e30b283290dd
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-017-3525-9
